| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.28 | 0.2 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.36 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |